nitroxoline has been researched along with EBV Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damoci, CB; Ibáñez de Garayo, M; Liu, W; Miranda, JJL; Rondeau, NC | 1 |
1 other study(ies) available for nitroxoline and EBV Infections
| Article | Year |
|---|---|
Rationally repurposed nitroxoline inhibits preclinical models of Epstein-Barr virus-associated lymphoproliferation.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Repositioning; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphocytes; Mice; Nitroquinolines; Xenograft Model Antitumor Assays | 2021 |